Non-canonical IL-2 signaling facilitates peripheral regulatory T cell differentiation

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Non-canonical IL-2 signaling, termed M onoclonal antibody or M atrix-directed A lternative C ytokine S ignaling (MACS), is mediated by a CD25–chemokine receptor complex and operates in concert with the canonical JAK-STAT5 pathway; however, its role in T cell homeostasis remains poorly defined. Here, we uncover a role for MACS in regulatory T cell (Treg) differentiation and functional specification. We generated Il2 E66K /E66K mice in which CD25–CCR7 assembly is disrupted and IL-2-induced STAT5 phosphorylation is preserved. Immunophenotyping analysis by flow cytometry revealed that MACS deficiency reduces the accumulation of Nrp1 - Foxp3 + Tregs in gut-associated lymphoid tissues from 24-weeks-old Il2 E66K/E66K mutant mice. Single-cell transcriptomics, functional suppression assays, and in vitro differentiation revealed that MACS engagement drives Treg differentiation and sustains effector Treg programs—marked by robust IL-10 expression—in part via an AP-1-dependent transcriptional network. These findings establish IL-2 MACS as a distinct signal directing peripheral immune tolerance and highlight a potential node for targeted immunomodulation.

One Sentence Summary

Non-canonical IL-2 signaling facilitates gut regulatory T cell development and suppressive function.

Article activity feed